Letters in Drug Design & Discovery

Author(s): William Brown, Thierry Hong Groblewski, Xiao Hong Yu, Rosemarie Panetta, Kemal Payza, Etienne Lessard, Stephane St-Onge, Mirek Tomaszewski, Christopher Walpole, Daniel Page, Hua Yang, Sanjay Srivastava, Claire Milburn, Helene Desfosses, Maxime Tremblay, Ziping Liu and Zhongyong Wei

DOI: 10.2174/157018010790596669

DownloadDownload PDF Flyer Cite As
5-Sulfonamide Benzimidazoles: A Class of Cannabinoid Receptors Agonists with Potent In Vivo Antinociception Activity

Page: [208 - 213] Pages: 6

  • * (Excluding Mailing and Handling)

Abstract

The synthesis and biological evaluation of a novel class of cannabinoid receptor agonists based on a 5- sulfonamide benzimidazole scaffold are reported. They showed a high binding affinity to both receptors with great in vivo potency. When given orally to rats, they produced a robust analgesia in different models of inflammatory and neuropathic pain.

Keywords: Benzimidazoles, Cannabinoid agonists, Antinociception